Loading…
Phreesia, Inc. is projected to rise to $14.16 by 2027, a +31% move from its current price of $10.79. PHR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $10.50 | $10.79 | $11.10 | +0.02% |
| Jul 13 | $10.38 | $10.79 | $11.23 | +0.04% |
| Jul 14 | $10.29 | $10.80 | $11.33 | +0.06% |
| Jul 15 | $10.21 | $10.80 | $11.42 | +0.08% |
| Jul 16 | $10.15 | $10.80 | $11.49 | +0.10% |
| Jul 17 | $10.09 | $10.80 | $11.56 | +0.12% |
| Jul 18 | $10.04 | $10.81 | $11.63 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.04 | $10.81 | $11.63 | +0.14% |
| Week 2 | $9.75 | $10.82 | $12.01 | +0.28% |
| Week 3 | $9.54 | $10.84 | $12.31 | +0.43% |
| Week 4 | $9.37 | $10.85 | $12.57 | +0.57% |
| Week 5 | $9.22 | $10.87 | $12.81 | +0.71% |
| Week 6 | $9.09 | $10.88 | $13.03 | +0.85% |
| Week 7 | $8.97 | $10.90 | $13.24 | +1.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions.
It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc.
was incorporated in 2005 and is based in Wilmington, Delaware.
Phreesia, Inc. is a healthcare-focused company that provides an integrated SaaS-based software and payment platform for healthcare organizations in the United States and Canada. It serves ambulatory practices, health systems, hospitals and other entities with AI-enabled workflows, digital intake tools, and on-site PhreesiaPads and Arrivals Kiosks.
The stock is currently priced at $10.94 with a market cap of $675.81M and a market rank of 2755. The current technical backdrop shows bullish sentiment, with RSI at 70, SMA50 at $9.48 and SMA200 at $14.93. The 30-day price range spans $8.90 to $13.45, with a $8.78 support and $10.94 resistance.
A major floor 25.3% below — a decisive break under it would weaken the trend.
The nearest floor, 17.3% below — buyers have tended to step in here.
Price is pressing into resistance (2.9% away) — a breakout level to watch.
A major ceiling 17.1% above — clearing it would confirm fresh momentum.
Key PHR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PHR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.85 | Sell | $10.75 | Buy |
| MA 10 | $10.66 | Buy | $10.55 | Buy |
| MA 20 | $9.94 | Buy | $10.20 | Buy |
| MA 50 | $9.63 | Buy | $9.98 | Buy |
| MA 100 | $10.13 | Buy | $11.04 | Sell |
| MA 200 | $14.60 | Sell | $14.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.43 | Neutral |
| Stoch RSI (14) | 69.58 | Neutral |
| CCI (20) | 72.62 | Neutral |
| Williams %R (14) | -17.43 | Info |
| MACD (12,26,9) | 0.10 | Buy |
| ROC (12) | 17.16 | Buy |
| Bollinger %B (20,2) | 0.76 | Neutral |
| Stochastic %K (14) | 82.57 | Sell |
| TRIX (15) | 0.43 | Buy |
| Awesome (5,34) | 1.10 | Buy |
| Ultimate (7,14,28) | 63.48 | Neutral |
| Momentum (10) | 1.59 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 10.83 | Sell |
| ADX (14) | 18.07 | Neutral |
| ATR (14) | 0.25 | Info |
The 30-day range is $8.90 to $13.45. RSI14 stands at 70, signaling bullish momentum. The 50-day simple moving average is $9.48 and the 200-day simple moving average is $14.93, with support at $8.78 and resistance at $10.94.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.06 | $10.79 | $15.10 | 0% | Neutral | |
| $11.25 | $14.16 | $18.86 | +31% | Bullish | |
| $11.95 | $15.48 | $21.40 | +43% | Bullish | |
| $11.79 | $15.63 | $22.26 | +45% | Bullish | |
| $13.07 | $17.69 | $25.82 | +64% | Bullish | |
| $13.65 | $18.83 | $28.09 | +75% | Bullish | |
| $15.09 | $21.18 | $32.20 | +96% | Bullish | |
| $18.63 | $26.59 | $41.14 | +146% | Bullish | |
| $19.97 | $28.96 | $45.53 | +168% | Bullish | |
| $20.32 | $29.92 | $47.75 | +177% | Bullish | |
| $29.42 | $46.39 | $78.82 | +330% | Bullish | |
| $44.05 | $78.19 | $145.49 | +625% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.06 | $10.79 | $13.16 | +0.00% |
| August 2026 | $9.33 | $11.02 | $13.37 | +2.15% |
| September 2026 | $9.24 | $10.99 | $13.49 | -0.28% |
| October 2026 | $9.62 | $11.52 | $14.27 | +4.78% |
| November 2026 | $9.98 | $12.00 | $14.98 | +4.21% |
| December 2026 | $9.93 | $12.00 | $15.10 | +0.01% |
Click any year to see its month-by-month PHR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PHR price prediction for 2026 points to an average of $10.79 (low $8.06, high $15.10) — a potential gain of 0% on today's $10.79. A consolidation phase looks the most probable path here.
In 2027, PHR is projected to trade between $11.25 and $18.86, averaging $14.16 — a potential gain of +31% from today's $10.79. That is up +31% on the projected 2026 average. Momentum favours further upside here.
Phreesia, Inc.'s 2028 outlook centres on $15.48, within a $11.95 to $21.40 range. That is up +9% on the projected 2027 average. That marks a +43% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, PHR could reach as high as $22.26, with a base case around $15.63 and support toward $11.79 — roughly +45% from $10.79. Momentum favours further upside here.
Expect PHR to range from $13.07 to $25.82 through 2030. The $17.69 average target implies a +64% move from current prices. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The PHR price prediction for 2031 points to an average of $18.83 (low $13.65, high $28.09) — a potential gain of +75% on today's $10.79. Momentum favours further upside here.
In 2032, PHR is projected to trade between $15.09 and $32.20, averaging $21.18 — a potential gain of +96% from today's $10.79. That is up +12% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Phreesia, Inc.'s 2033 outlook centres on $26.59, within a $18.63 to $41.14 range. That is up +26% on the projected 2032 average. That marks a +146% change versus current levels. Momentum favours further upside here.
By 2034, PHR could reach as high as $45.53, with a base case around $28.96 and support toward $19.97 — roughly +168% from $10.79. Buyers look set to stay in control over this stretch.
Expect PHR to range from $20.32 to $47.75 through 2035. The $29.92 average target implies a +177% move from current prices. That is up +3% on the projected 2034 average. Momentum favours further upside here.
The PHR price prediction for 2040 points to an average of $46.39 (low $29.42, high $78.82) — a potential gain of +330% on today's $10.79. Buyers look set to stay in control over this stretch.
In 2050, PHR is projected to trade between $44.05 and $145.49, averaging $78.19 — a potential gain of +625% from today's $10.79. That is up +69% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in PHR today (≈ 92.678406 PHR) could be worth
$7,246.28
+$6,246.28 (+625%) by 2050 · US Dollar
Based on the average projected PHR price of $78.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PHRwould be worth at today's price.
$1,000 invested in PHR on Jul 10, 2025 (≈ 34.879665 PHR) would be worth
$376.35
-$623.65 (-62.4%) today · 0.38× · US Dollar
Based on a PHR entry price of $28.67 vs. today's $10.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.94 | $986.29 | -1.4% |
| 1 month ago | $9.14 | $1,180.53 | +18.1% |
| 3 months ago | $8.06 | $1,338.71 | +33.9% |
| 6 months ago | $17.14 | $629.52 | -37.0% |
| 1 year ago | $28.67 | $376.35 | -62.4% |
| All time (5.0y) ago | $67.61 | $159.59 | -84.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PHR forecast.
Our base-case forecast reaches $22.00 around 2033.
Implied market cap at $22.00: $1.36B
The multi-year outlook shows a rising average price path. In 2026 the forecasted average price is $10.94 with a neutral sentiment and a 0 ROI. In 2027 the average price is $14.70 with a bullish sentiment and ROI of 34.4.
In 2028 the average price is $16.06 with a bullish sentiment and ROI of 46.8, and in 2029 the average price is $16.05 with a bullish sentiment and ROI of 46.8. The 2030 forecast projects an average price of $18.60 with bullish sentiment and ROI of 70. By 2040 the average price is forecast at $50.86 with bullish sentiment and ROI of 364.9, and by 2050 the average price is $85.05 with bullish sentiment and ROI of 677.4.
The range of outcomes widens over time, with 2040 and 2050 forecasting much higher price levels. These figures are estimates, not guarantees, and subject to market risk and volatility.
Tap a question to reveal the answer.
The 2030 forecast shows min $13.42, avg $18.60, max $27.88 with ROI 70 and bullish sentiment.
Forecasts show bullish sentiment from 2027 onward, with avg prices rising to $14.70 (2027), $16.06 (2028), $16.05 (2029), $18.60 (2030), $19.67 (2031), up to $85.05 (2050) and ROI up to 677.4. 2026 is neutral with avg $10.94 and ROI 0.
Yes. The 2040 forecast shows min $30.70, avg $50.86, max $89.96 with ROI 364.9 and bullish sentiment.
RSI14 is 70, sentiment bullish. The 30-day range is $8.90 to $13.45, with SMA50 at $9.48 and SMA200 at $14.93; support is $8.78 and resistance is $10.94.
Current price is $10.94 and market cap is $675.81M.
Phreesia, Inc. Community Discussion
0Share your Phreesia, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.